Plasma Aβ42/Aβ40 and p‐tau181 are associated with clinical progression in amnestic mild cognitive impairment: An 8‐year longitudinal study
Zhenxu Xiao(Fudan University), Ding Ding(Fudan University), Qiqi Lei(South China Agricultural University), Wanqing Wu(East China University of Science and Technology), Xiaoxi Ma(Fudan University), Li Zheng(Fudan University), Xiaoniu Liang(Fudan University), Ke‐Liang Chen(Fudan University), Saineng Ding(Fudan University), Qianhua Zhao(Fudan University)
Cited by 0
Related Papers
Standards for epidemiologic studies and surveillance of epilepsy
|Epilepsia|2011|1k
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia
|Alzheimer s Research & Therapy|2021|200
Environmental occurrence, toxicity concerns, and biodegradation of neonicotinoid insecticides
|Environmental Research|2022|169
Bioremediation potential of laccase for catalysis of glyphosate, isoproturon, lignin, and parathion: Molecular docking, dynamics, and simulation
|Journal of Hazardous Materials|2022|128
Novel pathway of acephate degradation by the microbial consortium ZQ01 and its potential for environmental bioremediation
|Journal of Hazardous Materials|2021|118